Conference Description

August 25-26, 2007
Westin Atlanta Perimeter North
7 Concourse Parkway
Atlanta, GA
770-395-3900

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated these conferences

CME Credits: 10.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:

This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis. This program will incorporate didactic lectures, case based learning, and utilize an audience response system to facilitate discussion among participants to enhance the educational opportunity.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. review early pathogenesis and prevention of type 2 diabetes, more effectively attain tight glucose control and discuss recent outcomes trials on the development and progression of atherosclerosis in diabetes
2. review glycemic and cardiovascular outcomes from insulin trials in type 2 diabetes, and optimize glycemic control with insulin in type 2 diabetes while minimizing weight gain and hypoglycemia
3. critically evaluate the evidence behind diagnostic and therapeutic options for constipation predomi nant irritable bowel syndrome and chronic constipation
4. outline an evidence based approach to the evaluation of insomnia and understand behavioral and pharmacological treatment approaches including their application in the clinical setting
5. utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life
6. understand the role of immune response modifiers in the treatment of warts; appreciate the mechanisms of action and efficacy of anti-inflammatory dose doxycycline in acne rosacea, and learn appropriate use of topical steroids and calcipotriene for the treatment of psoriasis
7. appreciate that given its favorable risk to benefit ratio, the more widespread and appropriate aggressive management of patients with statins will confer statisti - cally significant and clinically important reductions in myocardial infarction, stroke, and deaths from cardiovascular disease
8. more quickly and effectively recognize and diagnose cognitively impaired patients with increased under - standing of the pathology of dementia and evolving treatment strategies
9. identify the most pertinent adverse events seen in the Women’s Health Initiative and advise patients on the risks and benefits of traditional, non-traditional, and alternative medical interventions for addressing menopausal symptoms
10. recognize the underlying pathophysiology of BPH, utilize the AUA scoring system and choose appropriate pharmacotherapy and surgical interven - tions for BPH

Agenda:
Saturday, August 25, 2007

7:15-7:50 am		Registration, Continental Breakfast and Welcome
7:50-8:10		Welcome Remarks and Pre-Assessment Jack Kravitz, MD
8:10-9:10		Fundamentals of Quality Diabetes Care Patrick J. Boyle, MD
9:10-10:10		Insulin Therapy in Type 2 Diabetes – Who, When, and How Patrick J. Boyle, MD
10:10-10:30		Break
10:30-11:30		Evolving Concepts in GI Motility Disorders: IBS-Constipation and Chronic Constipation Brooks Cash, MD
11:30-12:30		Waking up to Insomnia Karl Doghramji, MD
12:30-1:30		Lunch
1:30-2:30		Restless Legs Syndrome Karl Doghramji, MD
2:30-3:30		Dermatology Therapy Update: Warts, Rosacea and Psoriasis Brian Berman, MD, PhD
3:30-3:50		Break
3:50-4:50		Update on Statins in the Treatment and Prevention of Cardiovascular Disease: Clinical and Public Health Challenges Charles Hennekens, MD, DrPH

Sunday, August 26, 2007

Faculty:
Brian Berman, MD, PhD
Professor of Dermatology and Internal Medicine
The University of Miami School of Medicine, Miami, FL

Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico, Albuquerque, NM

Brooks D. Cash, MD, FACP, FACG
Chief, Gastroenterology Division and Colon Health Initiative
Associate Professor of Medicine, USUHS
National Naval Medical Center, Bethesda, MD

Karl Doghramji, MD
Professor of Psychiatry, Jefferson Medical College
Director, Sleep Disorders Center,
Thomas Jefferson University, Philadelphia, PA

Charles Hennekens, MD, DrPH
Sir Richard Doll Research Professor of
Biomedical Science, Center of Excellence,
Florida Atlantic University
Voluntary Professor of Medicine & Epidemiology and Public Health,
University of Miami Miller School of Medicine
Clinical Professor of Preventive Medicine,
NOVA Southeastern University, Boca Raton, FL

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health & Family Medicine
University of Florida, Gainseville, FL

Walter C. Martinez, MD, FAAN
Director Memory Disorder Center
Director Premiere Research Institute
Associate Clinical Professor of Neurology at Nova
Southeastern University, Ft. Lauderdale, FL

Program Chair: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 10 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 10 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amylin, AstraZeneca, Bayer, Boehringer Ingelheim, Collagenex, Eisai, Merck, Novo nordisk, sanofi-aventis, Takeda, Wyeth.